The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
October 30th 2024
HLX14 (Organon) is an investigational biosimilar to denosumab (Prolia/Xgeva; Amgen).
Women Who Receive False Positive Mammography Results Are Less Likely to Attend Follow-Up Screenings
September 4th 2024The authors stress that health care providers should explain false positive results to their patients, reassure them that results may be negative, and stress the significance of continued screenings.
Read More
This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
Read More